FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
- Science
Gina Kolata and Pam Belluck
- 0
- 1 minute read
FDA Advisory Panel Endorses Approval of Alzheimer’s Drug Made by Eli Lilly
The modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
